---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-040324"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2026-08-27T11:32:37+00:00"
generated_at: "2026-08-27T11:35:15.081467+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# DNA X approves cash grants to board, incl. CEO, in lieu of RSUs

## Summary
- Cash grant based on phantom RSUs valued at $60,000, vesting at earlier of 2027 annual meeting or change in control.
- Grant made due to unavailability of shares under 2019 Equity Incentive Plan.
- Payable at fair market value of common stock at vesting event.
- All board members, including CEO Mike Mulica, receive the award.

## SEC filing metadata
- accession: 0001493152-26-040324
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2026-08-27T11:32:37+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315226040324/0001493152-26-040324-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315226040324/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-040324
- JSON: https://secwatch.observer/filing/0001493152-26-040324.json
- Plain text: https://secwatch.observer/filing/0001493152-26-040324.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.